ArticleArthritis research & therapy2015

Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts.

Paola Cipriani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.